Standardization of oncoplastic breast conserving surgery

Weber, Walter; Soysal, Savas D.; Fulco, Ilario; Barandun, Marina; Babst, Doris; Kalbermatten, Daniel F.; Schaefer, Dirk J.; Oertli, Daniel; Haug, Martin

doi:10.1016/j.ejso.2017.01.006

Cited by 93 publications

(50 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Breast-conserving surgery (BCS) followed by adjuvant radiotherapy, is documented to be equal to mastectomy with regard to oncological outcomes [1][2][3], and has to a large extent replaced total mastectomy in the last few decades. Oncoplastic breast surgery (OBS) was developed with the aim of further improving the esthetic and functional outcomes of BCS [4][5][6][7], as these affect health-related quality of life (HRQoL). However, only a few studies have addressed patient-reported outcomes (PROs), e.g., physical and psychosocial well-being, following OBS or among patients treated with conventional BCS [8,9].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer

Rose

Svensson

Handler

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

Introduction Oncoplastic breast surgery (OBS) has developed as an extension of breast-conserving surgery (BCS) in an effort to improve esthetic and functional outcome following surgery for breast cancer. The aim of the present study was to evaluate the possible benefits of OBS, as compared with BCS, with regard to health-related quality of life (HRQoL), using patient-reported outcome measures (PROMs). Patients and methods Patients treated with OBS (n = 200) and BCS (n = 1304) in the period 1 January 2008 to 31 December 2013 were identified in a research database and in the Danish Breast Cancer Cooperative Group (DBCG) registry. Data on patient, tumor, and treatment characteristics were retrieved from the DBCG registry. Patients were sent a survey including the Breast-Q™ BCT postoperative module and a study-specific questionnaire (SSQ) in 2016. A good outcome in the Breast-Q module was defined as above the median. OBS was compared to BCS using a logistic regression analysis, and then adjusted for potential confounders, yielding odds ratios (OR) with 95% confidence intervals. Results There was a statistically significant better outcome considering the HRQoL domain "Psychosocial Well-being " for patients treated with OBS as compared with BCS (OR 2.15: 1.25-3.69). No statistically significant differences were found for the domains "Physical Well-being" (0.83: 0.50-1.39), "Satisfaction with Breast" (0.95: 0.57-1.59), or "Sexual Wellbeing" (1.42: 0.78-2.58). Conclusion The present study indicates better outcomes of HRQoL for breast cancer patients treated with OBS as compared to patients treated with BCS. There was no increase in physical discomfort among OBS patients despite more extensive surgery.Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

show abstract

Section: Introductionmentioning

confidence: 99%

“…Several studies have evaluated oncoplastic surgery as a concept [4,5,7,10], others have considered surgical techniques [4,10], postoperative complications [6,10,11], as well as oncological [6,11,12] and esthetical outcomes [ Patients with E-post n = 1229…”

Section: Introductionmentioning

confidence: 99%

Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer

Rose

Svensson

Handler

et al. 2020

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…In the recent decades, the surgical management of breast cancer has steadily evolved from radical surgery to breast conservation. As a result, oncoplastic surgical techniques have emerged and are expanding dramatically . Oncoplastic surgery combines oncologic resection with immediate breast reconstruction using techniques derived from plastic surgery.…”

Section: Discussionmentioning

confidence: 99%

Oncoplastic breast surgery: Achieving oncological and aesthetic outcomes

Paridon

Kamali

Paul

et al. 2017

Journal of Surgical Oncology

View full text Add to dashboard Cite

show abstract

“…Oncoplastic breast-conserving surgery (BCS) has been developed to overcome the cosmetic disadvantages of conventional BCS and has become a commonly used procedure in patients with breast cancer [1]. Oncoplastic BCS can be divided into volume displacement and volume replacement techniques [2].…”

Section: Introductionmentioning

confidence: 99%

Volume replacement with diced acellular dermal matrix in oncoplastic breast-conserving surgery: a prospective single-center experience

et al. 2020

View full text Add to dashboard Cite

Background: Several studies have reported the use of acellular dermal matrix in breast reconstruction. However, the primary role of acellular dermal matrix in these studies was to support the implant; there are no reports on the use of acellular dermal matrix exclusively as volume replacement. Thus, we aimed to evaluate the safety and effectiveness of filling of the defect with acellular dermal matrix in oncoplastic breast-conserving surgery. Methods: We prospectively recruited 120 adult breast cancer patients who were scheduled to undergo oncoplastic breast-conserving surgery with acellular dermal matrix filling from 2017 to 2018. Intraoperatively, diced human acellular dermal matrix measuring 3-5 mm was used on each side to fill in the excisional defect immediately. After 6 months, satisfaction of the patients and surgeons with overall and cosmetic outcomes was evaluated with a survey using a 10-point scale. Postoperative complications were assessed at 2 weeks and 6 months postoperatively. Results: Of the 117 patients who were evaluated for their satisfaction, 94.0% were strongly satisfied with the cosmetic outcomes and 90.4% were strongly satisfied overall. Patient overall satisfaction scores were higher than surgeon satisfaction scores (p < 0.001). Of the 117 patients who underwent evaluation of complications 6 months postoperatively, six (5.1%) had hematoma and seven (6.0%) had seroma. The overall reoperation rate due to complications was 8.5%. Only two patients needed acellular dermal matrix removal due to hematoma and inflammation. Conclusion: Oncoplastic breast-conserving surgery with acellular dermal matrix filling of defects can be performed safely with high cosmetic satisfaction.

show abstract

Standardization of oncoplastic breast conserving surgery

Cited by 93 publications

References 32 publications

Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer

Patient-reported outcome after oncoplastic breast surgery compared with conventional breast-conserving surgery in breast cancer

Oncoplastic breast surgery: Achieving oncological and aesthetic outcomes

Volume replacement with diced acellular dermal matrix in oncoplastic breast-conserving surgery: a prospective single-center experience

Contact Info

Product

Resources

About